Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders.

Saved in:
Bibliographic Details
Title: Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders.
Authors: Westwell-Roper C; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada., Stewart SE; Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.; BC Mental Health and Substance Use Services Research Institute, Vancouver, BC, Canada.
Source: Frontiers in psychiatry [Front Psychiatry] 2020 Apr 22; Vol. 11, pp. 264. Date of Electronic Publication: 2020 Apr 22 (Print Publication: 2020).
Publication Type: Journal Article; Comment
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-0640
DOI:10.3389/fpsyt.2020.00264